IDH2 and glioblastoma: EGFR, encoding a transmembrane receptor tyrosine kinase acting in the PI3K/AKT/mTOR, MAPK, and other pathways, is among the genes most frequently activated by gene amplification, genetic rearrangements, and single nucleotide variants in IDH-wildtype glioblastomas [10].